Male sex hormones may influence the symptoms of irritable bowel syndrome in young men

BJ Kim, PL Rhee, JH Park, DK Chang, YH Kim, HJ Son… - Digestion, 1952 - karger.com
BJ Kim, PL Rhee, JH Park, DK Chang, YH Kim, HJ Son, JJ Kim, JC Rhee, H Lee
Digestion, 1952karger.com
Aims: To evaluate the sex hormone status of young male patients with irritable bowel
syndrome (IBS) and to investigate whether there were any differences in bowel symptoms
related to the hormone levels. Methods: Thirty-eight young male patients with IBS were
compared with 20 healthy young men. Details of symptoms were collected by a structured
questionnaire. Each subject underwent a blood test and colonoscopy. The blood test
included serum testosterone, free testosterone, sex hormone-binding globulin (SHBG) …
Aims
To evaluate the sex hormone status of young male patients with irritable bowel syndrome (IBS) and to investigate whether there were any differences in bowel symptoms related to the hormone levels.
Methods
Thirty-eight young male patients with IBS were compared with 20 healthy young men. Details of symptoms were collected by a structured questionnaire. Each subject underwent a blood test and colonoscopy. The blood test included serum testosterone, free testosterone, sex hormone-binding globulin (SHBG), follicle-stimulating hormone and luteinizing hormone. Based on the questionnaire, patients were classified as having diarrhea-predominant IBS (IBS-D) or constipation-predominant IBS (IBS-C).
Results
Among the 38 patients with IBS, 24 had IBS-D and 14 had IBS-C. The patients had higher levels of testosterone and SHBG than did the controls (p= 0.04 and p= 0.03, respectively). However, there was no significant difference between the IBS-D and IBS-C group with regard to the testosterone and SHBG levels (p> 0.05). There was also no difference in the duration and severity of symptoms between these 2 groups (p> 0.05).
Conclusions
Sex hormone status in young men differ from those in older men and may play an important role in the pathophysiology of IBS, regardless of the dominant symptom type.
Karger